VeriMomVeriMom
HIGH RISK

Hamilelikte n,n'-methylenebisacrylamide kullanmaktan kaçınmalı mıyım? | VeriMom

There are peer‑reviewed developmental toxicity studies in mice reporting decreased fetal body weight and increased fetal variations with N,N'-methylenebisacrylamide (110-26-9), indicating suspected developmental hazard (NOAEL for developmental toxicity reported at 3 mg/kg/day; adverse effects at higher doses). No harmonised CLP (Annex VI) reproductive classification was identified. For typical topical cosmetic use, dermal exposure/absorption from finished products is expected to be negligible. (Toxicological Sciences 1998; ECHA substance information; product SDSs/MSDSs reporting reproductive hazard category in supplier documents).

ECHA regulatory hazard statements

  • H340

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

n,n'-methylenebisacrylamide hamilelikte güvenli mi?
There are peer‑reviewed developmental toxicity studies in mice reporting decreased fetal body weight and increased fetal variations with N,N'-methylenebisacrylamide (110-26-9), indicating suspected developmental hazard (NOAEL for developmental toxicity reported at 3 mg/kg/day; adverse effects at higher doses). No harmonised CLP (Annex VI) reproductive classification was identified. For typical topical cosmetic use, dermal exposure/absorption from finished products is expected to be negligible. (Toxicological Sciences 1998; ECHA substance information; product SDSs/MSDSs reporting reproductive hazard category in supplier documents).
n,n'-methylenebisacrylamide emzirirken güvenli mi?
Same basis as pregnancy: animal developmental/reproductive studies show suspected developmental toxicity. There are no data showing transfer into human milk; for normal topical cosmetic use, exposure to a nursing infant via maternal milk is expected to be negligible. No authoritative cosmetic‑safety body (CIR/SCCS) reproductive clearance for this specific compound was located.
n,n'-methylenebisacrylamide bebek cildi için güvenli mi?
The hazard evidence (mouse developmental toxicity) supports a suspected reproductive/developmental hazard. Dermal exposure of infants (0–3 yr) is of greater concern than for adults because immature skin has higher surface‑area‑to‑weight and higher relative uptake; while adult topical cosmetic exposure is expected to be negligible, per the scoring rules infant exposure is increased by +1 when measurable absorption cannot be excluded. There are no infant‑specific toxicity data identified.
VeriMom n,n'-methylenebisacrylamide nasıl puanlıyor?
VeriMom n,n'-methylenebisacrylamide'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 39/100 (yüksek risk) olarak puanlar.
Hamilelikte n,n'-methylenebisacrylamide yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin